Celularity Inc. Cash and Restricted Cash
Celularity Inc. (CELU) had Cash and Restricted Cash of $16.37 million as of 2025-12-31, per its 10-K filed 2026-04-30.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-04-30
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $16.37M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $10.26M.
- 2025-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $10.94M.
- 2025-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $10.30M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2025-12-31 | $16.37M 10-K · filed 2026-04-30 | |
| 2025-09-30 | $10.26M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $10.94M 10-Q · filed 2025-08-29 | |
| 2025-03-31 | $10.30M 10-Q · filed 2025-08-29 | |
| 2024-12-31 | $10.98M 10-K · filed 2026-04-30 | |
| 2024-09-30 | $10.33M 10-Q · filed 2025-11-14 | $10.30M 10-Q · filed 2024-12-06 |
| 2024-06-30 | $10.55M 10-Q · filed 2025-08-29 | |
| 2024-03-31 | $11.95M 10-Q · filed 2025-08-29 | |
| 2023-12-31 | $10.16M 10-K · filed 2026-04-30 | |
| 2023-09-30 | $15.10M 10-Q · filed 2024-12-06 | |
| 2023-06-30 | $17.91M 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $23.36M 10-Q · filed 2024-10-16 | |
| 2022-12-31 | $28.80M 10-K · filed 2025-05-08 | |
| 2022-09-30 | $57.48M 10-Q · filed 2024-01-03 | |
| 2022-06-30 | $52.83M 10-Q · filed 2023-08-14 | |
| 2022-03-31 | $62.86M 10-Q · filed 2023-05-22 | |
| 2021-12-31 | $52.08M 10-K · filed 2024-07-30 | |
| 2021-09-30 | $87.44M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $22.92M 10-Q · filed 2022-08-09 | |
| 2021-03-31 | $38.11M 10-Q · filed 2022-05-16 | |
| 2020-12-31 | $69.51M 10-K · filed 2023-03-31 | |
| 2020-09-30 | $96.03M 10-Q · filed 2021-11-12 | |
| 2019-12-31 | $43.51M 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |